1
|
Peng L, Fang Z, Renauer PA, McNamara A, Park JJ, Lin Q, Zhou X, Dong MB, Zhu B, Zhao H, Wilen CB, Chen S. Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species. Cell Rep 2022; 40:111160. [PMID: 35921835 PMCID: PMC9294034 DOI: 10.1016/j.celrep.2022.111160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Revised: 05/07/2022] [Accepted: 07/13/2022] [Indexed: 12/02/2022] Open
Abstract
Although COVID-19 vaccines have been developed, multiple pathogenic coronavirus species exist, urging on development of multispecies coronavirus vaccines. Here we develop prototype lipid nanoparticle (LNP)-mRNA vaccine candidates against SARS-CoV-2 Delta, SARS-CoV, and MERS-CoV, and we test how multiplexing LNP-mRNAs can induce effective immune responses in animal models. Triplex and duplex LNP-mRNA vaccinations induce antigen-specific antibody responses against SARS-CoV-2, SARS-CoV, and MERS-CoV. Single-cell RNA sequencing profiles the global systemic immune repertoires and respective transcriptome signatures of vaccinated animals, revealing a systemic increase in activated B cells and differential gene expression across major adaptive immune cells. Sequential vaccination shows potent antibody responses against all three species, significantly stronger than simultaneous vaccination in mixture. These data demonstrate the feasibility, antibody responses, and single-cell immune profiles of multispecies coronavirus vaccination. The direct comparison between simultaneous and sequential vaccination offers insights into optimization of vaccination schedules to provide broad and potent antibody immunity against three major pathogenic coronavirus species.
Collapse
Affiliation(s)
- Lei Peng
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA
| | - Zhenhao Fang
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA
| | - Paul A Renauer
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA; Molecular Cell Biology, Genetics and Development Program, Yale University, New Haven, CT 06516, USA
| | - Andrew McNamara
- Department of Immunobiology, Yale University, New Haven, CT 06510, USA; Department of Laboratory Medicine, Yale University, New Haven, CT 06510, USA
| | - Jonathan J Park
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA; M.D.-Ph.D. Program, Yale University, West Haven, CT 06516, USA
| | - Qianqian Lin
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA
| | - Xiaoyu Zhou
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA
| | - Matthew B Dong
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA; Department of Immunobiology, Yale University, New Haven, CT 06510, USA; M.D.-Ph.D. Program, Yale University, West Haven, CT 06516, USA; Immunobiology Program, Yale University, New Haven, CT 06510, USA
| | - Biqing Zhu
- Computational Biology and Bioinformatics Program, Yale University, New Haven, CT 06510, USA
| | - Hongyu Zhao
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; Computational Biology and Bioinformatics Program, Yale University, New Haven, CT 06510, USA; Department of Biostatistics, Yale University School of Public Health, New Haven, CT 06510, USA; Yale Center for Biomedical Data Science, Yale University School of Medicine, New Haven, CT 06510, USA
| | - Craig B Wilen
- Department of Immunobiology, Yale University, New Haven, CT 06510, USA; Department of Laboratory Medicine, Yale University, New Haven, CT 06510, USA
| | - Sidi Chen
- Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; System Biology Institute, Yale University, West Haven, CT 06516, USA; Center for Cancer Systems Biology, Yale University, West Haven, CT 06516, USA; Molecular Cell Biology, Genetics and Development Program, Yale University, New Haven, CT 06516, USA; M.D.-Ph.D. Program, Yale University, West Haven, CT 06516, USA; Immunobiology Program, Yale University, New Haven, CT 06510, USA; Computational Biology and Bioinformatics Program, Yale University, New Haven, CT 06510, USA; Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA; Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT 06510, USA; Yale Center for Biomedical Data Science, Yale University School of Medicine, New Haven, CT 06510, USA.
| |
Collapse
|